< 生产厂家价格 >

7-溴吲哚

7-溴吲哚用途

7-Bromo-1H-indole 是一种生化试剂,可作为生物材料或有机化合物,用于生命科学相关研究。

点击显示

7-溴吲哚名称

[ CAS 号 ]:
51417-51-7

[ 中文名 ]:
7-溴吲哚

[ 英文名 ]:
7-Bromo-1H-indole

[中文别名 ]:

[英文别名 ]:

7-Bromoindole
1H-Indole,7-broMo
3-CYANO-7-CHLORO INDOLE
7-bromoidnole
7-Brom-indol
7-BROMOCHROMANONE
7-bromo indole
MFCD00799492
1H-Indole, 7-bromo-
7-Bromo-1H-indole

7-溴吲哚生物活性

[ 描述 ]:

7-Bromo-1H-indole 是一种生化试剂,可作为生物材料或有机化合物,用于生命科学相关研究。

[ 相关类别 ]:

研究领域 >> 其他

7-溴吲哚物理化学性质

[ 密度 ]:
1.7±0.1 g/cm3

[ 沸点 ]:
316.9±15.0 °C at 760 mmHg

[ 熔点 ]:
41-44 °C(lit.)

[ 分子式 ]:
C₈H₆BrN

[ 分子量 ]:
196.044

[ 闪点 ]:
145.5±20.4 °C

[ 精确质量 ]:
194.968353

[ PSA ]:
15.79000

[ LogP ]:
2.91

[ 外观性状 ]:
米色-淡黄色或褐色结晶粉末

[ 蒸汽压 ]:
0.0±0.7 mmHg at 25°C

[ 折射率 ]:
1.712

[ 储存条件 ]:
存放于惰性气体之中;避免光,空气

[ 水溶解性 ]:
可溶于：甲醇

7-溴吲哚MSDS

7-溴吲哚安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H319-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xn:Harmful

[ 风险声明 (欧洲) ]:
R20/21/22;R36/37/38

[ 安全声明 (欧洲) ]:
S26-S36-S36/37/39-S22

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
29339990

7-溴吲哚合成路线

7-溴吲哚上下游产品

7-溴吲哚上游产品

7-溴吲哚下游产品

7-溴吲哚海关

[ 海关编码 ]: 2933990090

[ 中文概述 ]:
2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

7-溴吲哚文献

Multicomponent phenol hydroxylase-catalysed formation of hydroxyindoles and dyestuffs from indole and its derivatives.

Lett. Appl. Microbiol. 41(2) , 163-8, (2005)

To establish multicomponent phenol hydroxylases (mPHs) as novel biocatalysts for producing dyestuffs and hydroxyindoles such as 7-hydroxyindole (7-HI) from indole and its derivatives.We have isolated ...

Indole and 7-benzyloxyindole attenuate the virulence of Staphylococcus aureus.

Appl. Microbiol. Biotechnol. 97(10) , 4543-52, (2013)

Human pathogens can readily develop drug resistance due to the long-term use of antibiotics that mostly inhibit bacterial growth. Unlike antibiotics, antivirulence compounds diminish bacterial virulen...

Diversity Oriented Synthesis: Concise Entry to Novel Derivatives of Yohimbine and Corynanthe Alkaloids.

Tetrahedron Lett. 53(5) , 477-479, (2012)

A novel MCAP-cycloaddition sequence has been applied to the facile synthesis of _-carboline intermediates to gain rapid access to novel derivatives of yohimbine-like and corynanthe-like compounds that...

更多文献